Equifax, Inc. EFX

148.11 (0.69) (0.46%) as of 25 Sep
Market cap
$17.5B
P/E
25.8×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Insider Decisions

Total buys 0.46
Total sells 38.46
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — 1 — — — — — — —
Sell 2 1 — — 4 — 1 2 — 1 — 1
Insider Ownership 1.55%

Capital & Financial Ratios

Market Cap 17,480.00
Revenue 6,444.50
Net Income 696.30
Free Cash Flow 1,105.00
Net Debt 3,886.70
Current Ratio 0.60
Debt/Equity 0.92
P/E ratio 25.85
P/S ratio 2.72
P/B ratio 3.99
Past 5Y EPS Growth 12.25%
This Y EPS Growth 11.90%
Next Y EPS Growth 18.62%
Next 5Y EPS Growth 17.06%
in millions of $

Dividends

Payout Ratio 0.37
Annual Dividend Rate 1.56
Annual Dividend Yield 0.64%
total individual payouts
2028 Powerpack
2027 Powerpack
2026 2.24
0.56
0.56
0.56
2025 1.89
0.39
0.50
0.50
0.50
2024 1.56
0.39
0.39
0.39
0.39
2023 1.56
0.39
0.39
0.39
0.39
2022 1.56
0.39
0.39
0.39
0.39
2021 1.56
0.39
0.39
0.39
0.39
2020 1.56
0.39
0.39
0.39
0.39
2019 1.56
0.39
0.39
0.39
0.39
2018 1.56
0.39
0.39
0.39
0.39
2017 1.56
0.39
0.39
0.39
0.39
2016 1.32
0.33
0.33
0.33
0.33
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 217 170 181 170
Receivables 908 958 1,013 1,104
Inventory — — — —
Other 89 98 75 141
1,356 1,361 1,412 1,581
2023 2024 2025 Q'26
Payables 198 138 206 127
ST’ Debt — — — —
Other 335 403 427 491
2,019 1,812 2,335 2,626
in millions of $

Compound Annual Growth

10y 5y 3y
Sales 8.59% 8.04% 5.85%
Cash Flow 7.71% 11.29% 28.75%
Earnings 4.40% 4.89% (1.75%)
Book Value 7.00% 7.57% 5.18%

Revenue

Mar Jun Sep Dec Year
’26 1,649 1,700 — — —
’25 1,442 1,537 1,545 1,551 6,075
’24 1,389 1,431 1,442 1,419 5,681
’23 1,302 1,318 1,319 1,327 5,265
’22 1,363 1,317 1,244 1,198 5,122
’21 1,213 1,235 1,223 1,253 4,924
’20 958 983 1,068 1,119 4,128
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Mar Jun Sep Dec Year
’26 242 340 — — —
’25 224 361 560 471 1,616
’24 253 268 480 325 1,325
’23 151 262 382 322 1,117
’22 (198) 275 355 325 757
’21 143 408 398 385 1,335
’20 31 251 367 297 946
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 122 205 — — —
’25 117 239 438 341 1,134
’24 121 131 356 206 813
’23 (7) 99 247 176 516
’22 (355) 116 202 169 133
’21 30 285 301 254 871
’20 (57) 146 250 185 525
in millions of $ · fiscal quarters ending in the months shown

EPS

Mar Jun Sep Dec Year
’26 1.42 1.54 — — —
’25 1.06 1.53 1.29 1.44 5.32
’24 1.00 1.31 1.13 1.39 4.84
’23 0.91 1.12 1.31 1.06 4.40
’22 1.80 1.63 1.34 0.88 5.65
’21 1.64 1.74 1.66 0.99 6.02
’20 0.92 0.78 1.82 0.61 4.24
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

1.7
1Buy 2 3Hold 4 5Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
91.72 89.59 88.68 90.69 103.01 161.87 145.98 159.95 213.02 199.98

Analyst estimates 2026–2028

Powerpack
Low Price
136.97 147.02 138.69 148.59 196.47 300.11 294.93 252.60 309.63 281.07
High Price
9,500 10,300 10,900 11,200 11,400 12,700 14,000 14,900 14,700 15,000
Employees
0 0 0 0 0 0 0 0 0 0
Revenue/Emp
3,145 3,362 3,412 3,508 4,128 4,924 5,122 5,265 5,681 6,075
Revenue
64.60% 63.99% 57.79% 56.62% 57.91% 59.77% 57.49% 55.65% 55.67% 56.45%
Gross Margin
728 747 370 (414) 685 949 930 718 811 895
EBT
23.15% 22.21% 10.86% (11.80%) 16.60% 19.28% 18.15% 13.63% 14.27% 14.73%
EBT Margin
495 598 317 (378) 526 749 700 552 607 664
Net Income
269 291 316 337 399 490 569 620 681 727
Depreciation
26.36 28.00 28.34 29.01 33.97 40.39 41.85 42.84 45.89 49.31
Revenue/Sh
4.10 4.89 2.49 (3.30) 4.28 6.11 5.69 4.44 4.88 5.36
Earnings/Sh
6.90 6.79 5.58 2.60 7.79 10.95 6.19 9.09 10.70 13.11
Cash Flow/Sh
(1.45) (1.75) (2.63) (3.31) (3.47) (3.81) (5.10) (4.89) (4.13) (3.91)
Capex/Sh
5.44 5.05 2.96 (0.71) 4.32 7.14 1.08 4.19 6.57 9.21
Free CF/Sh
22.81 26.97 26.21 21.69 26.42 29.54 32.46 37.04 38.89 37.53
Book Value/Sh
119 120 120 121 122 122 122 123 124 123
Shares
28.97 24.45 35.97 0.00 46.24 47.92 34.85 54.02 52.33 40.48
PE Ratio
4.51 4.27 3.29 4.83 5.68 7.25 4.74 5.60 5.55 4.40
PS Ratio
5.21 4.43 3.55 6.46 7.30 9.91 6.11 6.48 6.55 5.78
PB Ratio
5.13 4.69 3.99 5.68 6.06 8.11 5.62 6.46 6.28 5.04
EV/Sales
24.83 25.99 38.27 (232.15) 47.67 45.87 217.26 65.98 43.92 26.98
EV/FCF
823 816 672 314 946 1,335 757 1,117 1,325 1,616
Op' Cash Flow
(173) (210) (316) (400) (421) (464) (624) (601) (511) (481)
Capex
650 606 356 (86) 525 871 133 516 813 1,134
FCF
(587) (675) 76 (150) (5) (1,170) (645) (663) (451) (923)
Working Cap'
2,087 1,739 2,631 3,380 3,277 4,470 4,820 4,748 4,323 4,055
Total Debt
1,958 1,403 2,407 2,978 1,593 4,245 4,535 4,531 4,153 3,875
Net Debt
2,721 3,239 3,156 2,623 3,210 3,601 3,973 4,552 4,814 4,624
Sh' Equity
8.76% 8.45% 4.32% (5.10%) 5.94% 7.21% 6.16% 4.58% 5.03% 5.59%
ROA
11.02% 11.20% 5.03% (3.74%) 8.80% 9.06% 7.76% 6.42% 7.26% 8.05%
ROIC
19.28% 19.71% 9.71% (13.29%) 17.83% 21.85% 18.38% 12.79% 12.90% 13.99%
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Equifax, Inc. (EFX) key facts

  • Equifax, Inc. (EFX) is a Consulting Services company in the Industrials sector, listed on the New York Stock Exchange.
  • Equifax, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 6.92% from fiscal 2024.
  • Net income was $664.3 million, or $5.36 per share (basic), a net margin of 10.9%.
  • As of September 25, 2026, EFX traded at $148.11, a market capitalization of $17.5 billion.
  • At that price the stock trades at 25.8× trailing-twelve-month earnings and 2.7× sales.
  • Equifax, Inc. pays an annual dividend of $1.56 per share, a yield of 0.64%, with a payout ratio of 36.6%.
  • Return on equity was 14.0% and debt-to-equity 0.92.

Source: company filings (standardised) and stockrow calculations.

Equifax, Inc. (EFX) Latest News

News by impact score

Fine-tune

25 Sep

4

Equifax (EFX) fell 4.2% to $148.80, a 52-week low, about 42% below its last year's high. The decline tracks a jump in long-term borrowing costs, with the 30-year Treasury yield at its highest since 2004. A notable development: opening credit-scoring to a rival boosted VantageScore, ending FICO's monopoly; Equifax co-owns part of VantageScore. Despite the stock's slide, the business fundamentals remain: revenue in three segments (employment and income verification, U.S. credit files, and international operations) growing double digits. Mortgage volumes have stalled as high rates curb refinancing, depressing mortgage-related fees that drive the fee line. The moat rests with Workforce Solutions, which holds payroll records lenders and others rely on; the three-bureau system remains entrenched. Hedge funds have increased exposure; the stock trades around 16x next year's earnings, suggesting valuation is pessimistic about the mortgage cycle, not data value. Mortgage-rate-driven weakness in the fee line could materially weigh on near-term revenue despite double-digit growth in other segments.

3

TransUnion is advancing growth through technology, with the OneTru platform as a key lever. In H1 2026, the company completed major migrations of U.S. credit customers to OneTru and accelerated global product introductions. The migration underpins its 2026 enterprise priorities, while a faster product cadence supports broader revenue expansion. U.S. Markets revenues rose 11%, led by Financial Services and Emerging Verticals. International organic revenues grew 6% CC, with India and the U.K. in high-single-digit gains and Canada up 10%. Management raised guidance to at least high-single-digit organic CC revenue growth for the third consecutive year and double-digit adjusted EPS growth. OneTru adoption and new product launches are expected to sustain momentum into the second half of 2026. Equifax and FICO are cited as peers in the data and analytics space. TRU's OneTru momentum could heighten competitive pressure on Equifax, potentially affecting its market share and product strategy.

23 Sep

4

Equifax launches two real-time fraud-intelligence tools, Signal Score for Email and Signal Score for Device, to help e-commerce, financial services and telecoms block automated fraud at checkout and during new signups. Leveraging Equifax's proprietary data and identity linkage, the scores connect email and device signals to trusted consumer profiles via APIs, delivering instant trust scores at the start of a transaction. The tools target threats such as account takeovers, VPNs, emulators, location spoofing and synthetic identities, enabling faster decisioning with fewer manual reviews. They can be used together or separately and complement existing offerings like Consumer Insights. By tying digital session behavior to real-world identities, the solutions aim to strengthen risk posture while preserving a frictionless experience for legitimate customers. Real-time, API-driven signals broaden Equifax's fraud prevention capabilities and could materially affect revenue and competitive positioning in identity and risk services.

22 Sep

4

Equifax launches Healthcare Report Credential ID, an automated screening tool for healthcare credentialing verification and employment decisioning. The solution provides primary-source verification of licenses and certifications alongside Equifax identity data, aiming to speed provider onboarding and improve patient safety. The system outputs license type, status, and expiration date, and uses identity checks to aid fraud detection under FCRA. The move, amid projected shortages of physicians and nurses through 2027, targets faster hiring and broader coverage, expanding Equifax's pre-hire workflow suite and reinforcing its role in background checks and credentialing. Expanding the product offering in healthcare credentialing creates a scalable revenue stream and strengthens competitive position in a high-demand staffing market.

4 Sep

4

Bill Pulte directs Fannie Mae and Freddie Mac to approve VantageScore for mortgage lending, delivering a direct setback to FICO score usage and altering credit scoring competition involving Equifax. Mandated VantageScore adoption by major GSEs shifts scoring preferences away from FICO and materially changes Equifax revenue streams from credit data and scores.

3 Sep

3

TransUnion reported Q2 earnings, triggering buy, sell or hold assessments for its stock as a direct competitor in credit data services. TransUnion Q2 results offer sector benchmarks that can shift short-term sentiment and relative valuation for Equifax.

2 Sep

3

Equifax gains from data advantages and innovations amid refinancing risks. Data advantages and innovations create moderate competitive gains balanced by refinancing risks.

26 Aug

3

Equifax agrees to a $100 million settlement over credit score errors, with eligibility checks underway for potential payments to affected parties. The settlement creates a direct financial hit and short-term reputational pressure without shifting Equifax's core business trajectory.

5 Aug

3

Equifax's essential datasets are driving consistent company growth. Equifax datasets support steady growth with moderate effects on performance.

4 Aug

3

Equifax raised $1 billion through two consecutive note sales. Note sales increase Equifax debt while adding cash reserves that influence financial flexibility.

30 Jul

4

Equifax capital market earnings crash out. Earnings crash signals major negative shift in performance and investor sentiment for Equifax.

3

Equifax stock appears attractive despite mortgage market weakness and AI-related concerns. Equifax resilience to mortgage weakness and AI fears supports moderately noticeable effects on investor sentiment and performance.

29 Jul

4

Equifax leverages AI technology and rising mortgage demand to drive its next phase of growth. AI integration and mortgage demand create major strategic growth drivers for Equifax.

27 Jul

3

Equifax international revenues display mixed regional trends with unexpected variances in key markets and indicate moderate growth prospects ahead. International revenue trends may moderately affect Equifax financial outlook and investor views on global operations.

24 Jul

3

Equifax Q3 outlook pressured by contract signing delays, Oppenheimer says. Contract signing delays pressure Equifax Q3 outlook and may affect near-term financial performance.

21 Jul

5

Equifax achieves AI-driven cost savings, executes share buybacks, and closes a deal in Mexico positioned to transform operations and market standing. AI savings, buybacks and Mexico deal represent transformative initiatives that fundamentally improve Equifax efficiency and growth outlook.

4

Equifax Inc reported strong revenue growth in Q2 2026 with strategic initiatives highlighted during the earnings call. Strong revenue growth and strategic moves in earnings point to material shifts in financial performance and investor outlook.

4

Equifax reports 11% revenue growth for Q2 2026. Company signs agreement to acquire Círculo de Crédito. AI-driven cost reduction target doubles to $150 million. $366 million cash returned to shareholders. Acquisition of Círculo de Crédito plus doubled cost savings target represent major strategic expansion and efficiency gains that alter growth trajectory.

3 transcript

Equifax Inc. summarized Q2 2026 earnings call results including financial performance metrics and forward guidance. Quarterly earnings details may shift short-term investor sentiment and valuation multiples without altering long-term strategy.

3

Equifax reported Q2 earnings call highlights covering financial results, operational metrics, and forward guidance. Q2 earnings results can influence investor perceptions of Equifax's financial health and growth prospects.

3

Equifax Q2 earnings beat estimates driven by USIS and mortgage segment growth. Q2 earnings beat on USIS and mortgage growth signals moderately positive but non-transformative effects on Equifax operations and sentiment.

3

Equifax (EFX) beat analyst estimates for both Q2 earnings and revenue. Q2 earnings and revenue beat signals stronger financial results that can lift near-term investor sentiment and stock movement.

3

Equifax shares fall as weaker outlook overshadows second-quarter earnings beat. Weaker outlook triggers share decline despite earnings beat, pointing to moderate pressure on future performance and sentiment.

3

Equifax reported higher Q2 adjusted earnings and operating revenue while issuing its Q3 outlook. Quarterly earnings growth and forward outlook can moderately shift near-term investor views and trading.

19 Jul

3

Equifax (EFX) is scheduled to report earnings tomorrow. Upcoming earnings release may affect short-term stock price and sentiment.

12 Jul

4

Equifax acquires Círculo de Crédito for $750 million, expanding its credit reporting operations in Mexico. $750 million acquisition of Círculo de Crédito delivers major strategic expansion of Equifax operations and market share in Mexico.

8 Jul

4

Equifax is acquiring Círculo De Crédito for $750 million in a transaction that will test the company's valuation. $750 million acquisition of Círculo De Crédito marks a major strategic expansion that can significantly alter Equifax's trajectory.

7 Jul

3

Equifax announces definitive agreement to acquire Círculo de Crédito, expanding its credit reporting operations in Mexico. Acquisition expands Equifax presence in Mexican credit market.

11 Jun

3

Equifax sustains revenue growth despite low liquidity challenges. Revenue growth supports operations while low liquidity creates moderate financial risk.

5 Jun

3

Equifax Q1 earnings are compared against peers in the data and business process services sector. Q1 earnings figures can shift near-term investor views on Equifax financial trajectory.

stockrow.com/EFX · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com